Lv5
890 积分 2022-07-17 加入
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
13小时前
已完结
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor
5个月前
已完结
The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?
5个月前
已完结
Histone deacetylase complexes: Structure, regulation and function
6个月前
已关闭
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients
6个月前
已完结
HDAC3 inhibitors: a patent review of their broad-spectrum applications as therapeutic agents
6个月前
已完结
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer
7个月前
已关闭
Combinatorial strategies to target RAS-driven cancers
7个月前
已完结
Conserved mechanisms of NuRD function in hematopoetic gene expression
8个月前
已完结
Conserved mechanisms of NuRD function in hematopoetic gene expression
8个月前
已完结
皖公网安备34019202002308
